Related Experiment Video
Updated: Feb 25, 2026
07:31
A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
7.5K
Pharmacist perceptions of competency: Identifying priority areas for a competency program development at an academic
Jami E Mann1, Lindsey B Amerine1, Kayla Waldron1
1University of North Carolina Medical Center, 101 Manning Drive, CB#7600, Chapel Hill, NC, 27514, United States.
Research in Social & Administrative Pharmacy : RSAP
|July 30, 2017
Summary
Pharmacists identified therapeutic knowledge as a key area for competency development, highlighting a shared responsibility between individuals and healthcare organizations for continuous professional growth.
Area of Science:
- Healthcare Education
- Pharmacy Practice
- Professional Development
Background:
- Competency-based education models are vital for quality healthcare continuing education.
- Challenges in competency programs include limited stakeholder input and resource awareness.
- Involving pharmacists in program design is crucial for addressing needs.
Purpose of the Study:
- To assess pharmacist perceptions of competency development needs.
- To identify high-priority competency areas based on value, confidence, and usage.
- To inform the design of targeted professional development programs.
Main Methods:
- A survey was administered to pharmacists at an academic medical center.
- Opinions on perceived value, personal confidence, and frequency of use for nine competencies were collected.
- Priority areas were determined by analyzing aggregated scores for value, confidence, and usage.
Main Results:
- 105 pharmacists responded (78.9% response rate).
- Most pharmacists view competency assessment as a shared duty.
- Therapeutic knowledge was prioritized due to high perceived value and usage, coupled with low confidence.
Conclusions:
- Competency development is essential for pharmacists in a dynamic healthcare landscape.
- Organizations must align pharmacist competencies with institutional and individual needs.
- A model for shared responsibility in competency development was identified at an academic medical center.
Keywords:
Competency developmentNeeds assessmentPharmacy practiceProfessional developmentTherapeutic knowledgeMore Related Videos
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
37
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
37
01:28Biopharmaceutics and Pharmacokinetics: Overview
4.5K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.5K
01:29Pharmacogenetics and Pharmacogenomics: Overview
70
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
70
01:15Drug Dosing: Geriatric Patients
321
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
321
01:28Preclinical Development: Overview
6.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.1K
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
46
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
46